US Stock MarketDetailed Quotes

RENB Renovaro

Watchlist
  • 1.005
  • -0.185-15.55%
Close Feb 27 16:00 ET
  • 0.980
  • -0.025-2.49%
Post 20:01 ET
159.51MMarket Cap-1.29P/E (TTM)

About Renovaro Company

Renovaro, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.

Company Profile

SymbolRENB
Company NameRenovaro
Listing DateDec 10, 2018
Founded2011
CEOMr. David Weinstein
MarketNASDAQ
Employees25
Fiscal Year Ends06-30
Address2080 Century Park East,Suite 906
CityLos Angeles
ProvinceCalifornia
CountryUnited States of America
Zip Code90067
Phone1-305-918-1980

Company Executives

  • Name
  • Position
  • Salary
  • Maurice van Tilburg
  • Director; Chief Executive Officer, GEDi Cube B.V
  • --
  • David Weinstein
  • Chief Executive Officer and Director
  • --
  • Nathen Fuentes, C.P.A.
  • Chief Financial Officer
  • --
  • Douglas W. Calder
  • Director
  • --
  • James A. Mcnulty, C.P.A.
  • Director
  • --
  • Dr. Mark A. Collins, PhD
  • Director
  • --

Trending Stocks

Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More